Tylenol maker rebounds a day after Trump's unfounded claims about its safety

FILE - In this Dec. 12, 2007 file photo, Tylenol drugs are shown in the drug department at Costco in Mountain View, Calif. (AP Photo/Paul Sakuma, File)

Shares of Tylenol maker Kenvue bounced back sharply before the opening bell Tuesday, a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism.

“Don’t take Tylenol,” instructed pregnant women around a dozen times during the White House news conference Monday, also urging mothers not to give their infants the drug, known by the generic name acetaminophen in the U.S. or paracetamol in most other countries.

The ɫtv Press. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from ɫtvNews in your inbox. Select the emails you're interested in below.